ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fatty Acid Oxidation Disorder Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2L10562
Home | Market Reports | Health| Pharmacy
Global Fatty Acid Oxidation Disorder Market Insights Forecast to 2028
BUY CHAPTERS

Global Fatty Acid Oxidation Disorder Market Research Report 2025

Code: QYRE-Auto-2L10562
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biosynth
Daiichi Sankyo
Northeast Pharmaceutical Group
Merck KGaA
Mylan Laboratories
Chengda Pharmaceuticals
Sigma-Tau Pharmaceuticals
Bedford Laboratories
Spectrum Chemical Manufacturing Corporation
AminoScience

Fatty Acid Oxidation Disorder Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Fatty Acid Oxidation Disorder Market

Fatty Acid Oxidation Disorder Market

The global market for Fatty Acid Oxidation Disorder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fatty Acid Oxidation Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Acid Oxidation Disorder.
The Fatty Acid Oxidation Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fatty Acid Oxidation Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Acid Oxidation Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Fatty Acid Oxidation Disorder Market Report

Report Metric Details
Report Name Fatty Acid Oxidation Disorder Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biosynth AG, Daiichi Sankyo, Northeast Pharmaceutical Group, Merck KGaA, Mylan Laboratories, AminoScience, Chengda Pharmaceuticals, Sigma-Tau Pharmaceuticals, Bedford Laboratories, Spectrum Chemical Manufacturing Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Fatty Acid Oxidation Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fatty Acid Oxidation Disorder Market report?

Ans: The main players in the Fatty Acid Oxidation Disorder Market are Biosynth AG, Daiichi Sankyo, Northeast Pharmaceutical Group, Merck KGaA, Mylan Laboratories, AminoScience, Chengda Pharmaceuticals, Sigma-Tau Pharmaceuticals, Bedford Laboratories, Spectrum Chemical Manufacturing Corporation

What are the Application segmentation covered in the Fatty Acid Oxidation Disorder Market report?

Ans: The Applications covered in the Fatty Acid Oxidation Disorder Market report are Hospital pharmacies, Retail pharmacies, Drug stores, Online stores

What are the Type segmentation covered in the Fatty Acid Oxidation Disorder Market report?

Ans: The Types covered in the Fatty Acid Oxidation Disorder Market report are Oral, Intravenous Injection

Recommended Reports

Rare and Metabolic Diseases

Autoimmune and Genetic Disorders

Cardio and Metabolic Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Acid Oxidation Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Intravenous Injection
1.3 Market by Application
1.3.1 Global Fatty Acid Oxidation Disorder Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital pharmacies
1.3.3 Retail pharmacies
1.3.4 Drug stores
1.3.5 Online stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Acid Oxidation Disorder Market Perspective (2020-2031)
2.2 Global Fatty Acid Oxidation Disorder Growth Trends by Region
2.2.1 Global Fatty Acid Oxidation Disorder Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fatty Acid Oxidation Disorder Historic Market Size by Region (2020-2025)
2.2.3 Fatty Acid Oxidation Disorder Forecasted Market Size by Region (2026-2031)
2.3 Fatty Acid Oxidation Disorder Market Dynamics
2.3.1 Fatty Acid Oxidation Disorder Industry Trends
2.3.2 Fatty Acid Oxidation Disorder Market Drivers
2.3.3 Fatty Acid Oxidation Disorder Market Challenges
2.3.4 Fatty Acid Oxidation Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fatty Acid Oxidation Disorder Players by Revenue
3.1.1 Global Top Fatty Acid Oxidation Disorder Players by Revenue (2020-2025)
3.1.2 Global Fatty Acid Oxidation Disorder Revenue Market Share by Players (2020-2025)
3.2 Global Fatty Acid Oxidation Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fatty Acid Oxidation Disorder Revenue
3.4 Global Fatty Acid Oxidation Disorder Market Concentration Ratio
3.4.1 Global Fatty Acid Oxidation Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Acid Oxidation Disorder Revenue in 2024
3.5 Global Key Players of Fatty Acid Oxidation Disorder Head office and Area Served
3.6 Global Key Players of Fatty Acid Oxidation Disorder, Product and Application
3.7 Global Key Players of Fatty Acid Oxidation Disorder, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Acid Oxidation Disorder Breakdown Data by Type
4.1 Global Fatty Acid Oxidation Disorder Historic Market Size by Type (2020-2025)
4.2 Global Fatty Acid Oxidation Disorder Forecasted Market Size by Type (2026-2031)
5 Fatty Acid Oxidation Disorder Breakdown Data by Application
5.1 Global Fatty Acid Oxidation Disorder Historic Market Size by Application (2020-2025)
5.2 Global Fatty Acid Oxidation Disorder Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Fatty Acid Oxidation Disorder Market Size (2020-2031)
6.2 North America Fatty Acid Oxidation Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fatty Acid Oxidation Disorder Market Size by Country (2020-2025)
6.4 North America Fatty Acid Oxidation Disorder Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fatty Acid Oxidation Disorder Market Size (2020-2031)
7.2 Europe Fatty Acid Oxidation Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fatty Acid Oxidation Disorder Market Size by Country (2020-2025)
7.4 Europe Fatty Acid Oxidation Disorder Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fatty Acid Oxidation Disorder Market Size (2020-2031)
8.2 Asia-Pacific Fatty Acid Oxidation Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fatty Acid Oxidation Disorder Market Size by Region (2020-2025)
8.4 Asia-Pacific Fatty Acid Oxidation Disorder Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fatty Acid Oxidation Disorder Market Size (2020-2031)
9.2 Latin America Fatty Acid Oxidation Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fatty Acid Oxidation Disorder Market Size by Country (2020-2025)
9.4 Latin America Fatty Acid Oxidation Disorder Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fatty Acid Oxidation Disorder Market Size (2020-2031)
10.2 Middle East & Africa Fatty Acid Oxidation Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fatty Acid Oxidation Disorder Market Size by Country (2020-2025)
10.4 Middle East & Africa Fatty Acid Oxidation Disorder Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biosynth AG
11.1.1 Biosynth AG Company Details
11.1.2 Biosynth AG Business Overview
11.1.3 Biosynth AG Fatty Acid Oxidation Disorder Introduction
11.1.4 Biosynth AG Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.1.5 Biosynth AG Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Details
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Fatty Acid Oxidation Disorder Introduction
11.2.4 Daiichi Sankyo Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.2.5 Daiichi Sankyo Recent Development
11.3 Northeast Pharmaceutical Group
11.3.1 Northeast Pharmaceutical Group Company Details
11.3.2 Northeast Pharmaceutical Group Business Overview
11.3.3 Northeast Pharmaceutical Group Fatty Acid Oxidation Disorder Introduction
11.3.4 Northeast Pharmaceutical Group Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.3.5 Northeast Pharmaceutical Group Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Fatty Acid Oxidation Disorder Introduction
11.4.4 Merck KGaA Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Mylan Laboratories
11.5.1 Mylan Laboratories Company Details
11.5.2 Mylan Laboratories Business Overview
11.5.3 Mylan Laboratories Fatty Acid Oxidation Disorder Introduction
11.5.4 Mylan Laboratories Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.5.5 Mylan Laboratories Recent Development
11.6 AminoScience
11.6.1 AminoScience Company Details
11.6.2 AminoScience Business Overview
11.6.3 AminoScience Fatty Acid Oxidation Disorder Introduction
11.6.4 AminoScience Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.6.5 AminoScience Recent Development
11.7 Chengda Pharmaceuticals
11.7.1 Chengda Pharmaceuticals Company Details
11.7.2 Chengda Pharmaceuticals Business Overview
11.7.3 Chengda Pharmaceuticals Fatty Acid Oxidation Disorder Introduction
11.7.4 Chengda Pharmaceuticals Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.7.5 Chengda Pharmaceuticals Recent Development
11.8 Sigma-Tau Pharmaceuticals
11.8.1 Sigma-Tau Pharmaceuticals Company Details
11.8.2 Sigma-Tau Pharmaceuticals Business Overview
11.8.3 Sigma-Tau Pharmaceuticals Fatty Acid Oxidation Disorder Introduction
11.8.4 Sigma-Tau Pharmaceuticals Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.8.5 Sigma-Tau Pharmaceuticals Recent Development
11.9 Bedford Laboratories
11.9.1 Bedford Laboratories Company Details
11.9.2 Bedford Laboratories Business Overview
11.9.3 Bedford Laboratories Fatty Acid Oxidation Disorder Introduction
11.9.4 Bedford Laboratories Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.9.5 Bedford Laboratories Recent Development
11.10 Spectrum Chemical Manufacturing Corporation
11.10.1 Spectrum Chemical Manufacturing Corporation Company Details
11.10.2 Spectrum Chemical Manufacturing Corporation Business Overview
11.10.3 Spectrum Chemical Manufacturing Corporation Fatty Acid Oxidation Disorder Introduction
11.10.4 Spectrum Chemical Manufacturing Corporation Revenue in Fatty Acid Oxidation Disorder Business (2020-2025)
11.10.5 Spectrum Chemical Manufacturing Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biosynth
Daiichi Sankyo
Northeast Pharmaceutical Group
Merck KGaA
Mylan Laboratories
Chengda Pharmaceuticals
Sigma-Tau Pharmaceuticals
Bedford Laboratories
Spectrum Chemical Manufacturing Corporation
AminoScience
List of Tables
 Table 1. Global Fatty Acid Oxidation Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Intravenous Injection
 Table 4. Global Fatty Acid Oxidation Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Fatty Acid Oxidation Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Fatty Acid Oxidation Disorder Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Fatty Acid Oxidation Disorder Market Share by Region (2020-2025)
 Table 8. Global Fatty Acid Oxidation Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Fatty Acid Oxidation Disorder Market Share by Region (2026-2031)
 Table 10. Fatty Acid Oxidation Disorder Market Trends
 Table 11. Fatty Acid Oxidation Disorder Market Drivers
 Table 12. Fatty Acid Oxidation Disorder Market Challenges
 Table 13. Fatty Acid Oxidation Disorder Market Restraints
 Table 14. Global Fatty Acid Oxidation Disorder Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Fatty Acid Oxidation Disorder Market Share by Players (2020-2025)
 Table 16. Global Top Fatty Acid Oxidation Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Oxidation Disorder as of 2024)
 Table 17. Ranking of Global Top Fatty Acid Oxidation Disorder Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Fatty Acid Oxidation Disorder Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Fatty Acid Oxidation Disorder, Headquarters and Area Served
 Table 20. Global Key Players of Fatty Acid Oxidation Disorder, Product and Application
 Table 21. Global Key Players of Fatty Acid Oxidation Disorder, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Fatty Acid Oxidation Disorder Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Fatty Acid Oxidation Disorder Revenue Market Share by Type (2020-2025)
 Table 25. Global Fatty Acid Oxidation Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Fatty Acid Oxidation Disorder Revenue Market Share by Type (2026-2031)
 Table 27. Global Fatty Acid Oxidation Disorder Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Fatty Acid Oxidation Disorder Revenue Market Share by Application (2020-2025)
 Table 29. Global Fatty Acid Oxidation Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Fatty Acid Oxidation Disorder Revenue Market Share by Application (2026-2031)
 Table 31. North America Fatty Acid Oxidation Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Fatty Acid Oxidation Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Fatty Acid Oxidation Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Fatty Acid Oxidation Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Fatty Acid Oxidation Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Fatty Acid Oxidation Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Fatty Acid Oxidation Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Fatty Acid Oxidation Disorder Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Fatty Acid Oxidation Disorder Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fatty Acid Oxidation Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Fatty Acid Oxidation Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Fatty Acid Oxidation Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Fatty Acid Oxidation Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Fatty Acid Oxidation Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Fatty Acid Oxidation Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Biosynth AG Company Details
 Table 47. Biosynth AG Business Overview
 Table 48. Biosynth AG Fatty Acid Oxidation Disorder Product
 Table 49. Biosynth AG Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 50. Biosynth AG Recent Development
 Table 51. Daiichi Sankyo Company Details
 Table 52. Daiichi Sankyo Business Overview
 Table 53. Daiichi Sankyo Fatty Acid Oxidation Disorder Product
 Table 54. Daiichi Sankyo Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 55. Daiichi Sankyo Recent Development
 Table 56. Northeast Pharmaceutical Group Company Details
 Table 57. Northeast Pharmaceutical Group Business Overview
 Table 58. Northeast Pharmaceutical Group Fatty Acid Oxidation Disorder Product
 Table 59. Northeast Pharmaceutical Group Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 60. Northeast Pharmaceutical Group Recent Development
 Table 61. Merck KGaA Company Details
 Table 62. Merck KGaA Business Overview
 Table 63. Merck KGaA Fatty Acid Oxidation Disorder Product
 Table 64. Merck KGaA Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 65. Merck KGaA Recent Development
 Table 66. Mylan Laboratories Company Details
 Table 67. Mylan Laboratories Business Overview
 Table 68. Mylan Laboratories Fatty Acid Oxidation Disorder Product
 Table 69. Mylan Laboratories Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 70. Mylan Laboratories Recent Development
 Table 71. AminoScience Company Details
 Table 72. AminoScience Business Overview
 Table 73. AminoScience Fatty Acid Oxidation Disorder Product
 Table 74. AminoScience Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 75. AminoScience Recent Development
 Table 76. Chengda Pharmaceuticals Company Details
 Table 77. Chengda Pharmaceuticals Business Overview
 Table 78. Chengda Pharmaceuticals Fatty Acid Oxidation Disorder Product
 Table 79. Chengda Pharmaceuticals Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 80. Chengda Pharmaceuticals Recent Development
 Table 81. Sigma-Tau Pharmaceuticals Company Details
 Table 82. Sigma-Tau Pharmaceuticals Business Overview
 Table 83. Sigma-Tau Pharmaceuticals Fatty Acid Oxidation Disorder Product
 Table 84. Sigma-Tau Pharmaceuticals Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 85. Sigma-Tau Pharmaceuticals Recent Development
 Table 86. Bedford Laboratories Company Details
 Table 87. Bedford Laboratories Business Overview
 Table 88. Bedford Laboratories Fatty Acid Oxidation Disorder Product
 Table 89. Bedford Laboratories Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 90. Bedford Laboratories Recent Development
 Table 91. Spectrum Chemical Manufacturing Corporation Company Details
 Table 92. Spectrum Chemical Manufacturing Corporation Business Overview
 Table 93. Spectrum Chemical Manufacturing Corporation Fatty Acid Oxidation Disorder Product
 Table 94. Spectrum Chemical Manufacturing Corporation Revenue in Fatty Acid Oxidation Disorder Business (2020-2025) & (US$ Million)
 Table 95. Spectrum Chemical Manufacturing Corporation Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Fatty Acid Oxidation Disorder Picture
 Figure 2. Global Fatty Acid Oxidation Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fatty Acid Oxidation Disorder Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Intravenous Injection Features
 Figure 6. Global Fatty Acid Oxidation Disorder Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Fatty Acid Oxidation Disorder Market Share by Application: 2024 VS 2031
 Figure 8. Hospital pharmacies Case Studies
 Figure 9. Retail pharmacies Case Studies
 Figure 10. Drug stores Case Studies
 Figure 11. Online stores Case Studies
 Figure 12. Fatty Acid Oxidation Disorder Report Years Considered
 Figure 13. Global Fatty Acid Oxidation Disorder Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Fatty Acid Oxidation Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Fatty Acid Oxidation Disorder Market Share by Region: 2024 VS 2031
 Figure 16. Global Fatty Acid Oxidation Disorder Market Share by Players in 2024
 Figure 17. Global Top Fatty Acid Oxidation Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Oxidation Disorder as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Fatty Acid Oxidation Disorder Revenue in 2024
 Figure 19. North America Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Fatty Acid Oxidation Disorder Market Share by Country (2020-2031)
 Figure 21. United States Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Fatty Acid Oxidation Disorder Market Share by Country (2020-2031)
 Figure 25. Germany Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Fatty Acid Oxidation Disorder Market Share by Region (2020-2031)
 Figure 33. China Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Fatty Acid Oxidation Disorder Market Share by Country (2020-2031)
 Figure 41. Mexico Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Fatty Acid Oxidation Disorder Market Share by Country (2020-2031)
 Figure 45. Turkey Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Fatty Acid Oxidation Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Biosynth AG Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 49. Daiichi Sankyo Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 50. Northeast Pharmaceutical Group Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 51. Merck KGaA Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 52. Mylan Laboratories Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 53. AminoScience Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 54. Chengda Pharmaceuticals Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 55. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 56. Bedford Laboratories Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 57. Spectrum Chemical Manufacturing Corporation Revenue Growth Rate in Fatty Acid Oxidation Disorder Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Drugs for Fatty Acid Oxidation Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amino Acid Metabolism Disorder Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipid lowering Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acid Sphingomyelinase Deficiency Drug Market Research Report 2025
Drugs to Treat Hypertriglyceridemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Propionic Acidemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipids Active Pharmaceutical Ingredient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypertriglyceridemia Treatment Market Research Report 2025
Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Edwards Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions